Tumour necrosis factor and interferon are selectively cytostatic in vitro far hormone-dependent and hormone-independent human breast cancer cells

European Journal of Cancer Part A

Volumn 32, Issue 13, 1996, Pages 2312-2318

  Mueller, H ^a   Flury, N ^a   Liu, R ^a   Scheidegger, S ^a   Eppenberger, U ^a  

^a University Clinics Medical School   (Switzerland)

Author keywords

Breast cancer; Hormone dependency; Interferon gamma; Tumour necrosis factor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HORMONE RECEPTOR; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL CULTURE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; PROTO ONCOGENE;

BREAST NEOPLASMS; CELL DIVISION; DRUG SYNERGISM; FEMALE; GENES, MYC; HUMANS; INTERFERON TYPE II; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030459292     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00273-0     Document Type: Article

References (30)

1. 1. Sugerman BJ, Aggarwal BB, Hass PE, et al. Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 1985, 230, 943-945.
2. 2. Fransen L, Van der Heyden J, Ruysschaert R, Fiers W. Recombinant tumor necrosis factor: its effect and its synergism with interferon gamma on a variety of normal and transformed human cell lines. Eur J Cancer Clin Oncol 1986, 22, 419-426.
3. 3. Dealtry GB, Naylor MS, Fiers W, Balkwill FR. The effect of recombinant human tumor necrosis factor on growth and macromolecular synthesis of human epithelial cells. Exp Cell Res 1987, 170, 428-438.
4. 4. Spriggs D, Imamura K, Rodriguez C, Horiguchi C, Kufwe DW. Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. Proc Natl Acad Sci USA 1987, 84, 6563-6566.
5. 5. Ruggiero V, Latham K, Baglioni C. Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells. J Immunol 1987, 138, 1711-1717.
6. 6. Budd GT, Green S, Baker LH, et al. A Southwest Oncology Group phase II trial of recombinant tumor necrosis factor in metastatic breast cancer. Cancer 1991, 68, 1694-1695.
7. 7. Chapman PB, Lester TJ, Casper ES, et al. Clinical pharmacology of recombinant tumor necrosis factor in patients with advanced cancer. J Clin Oncol 1987, 5, 1942-1951.
8. 8. Blick M, Sherwin SA, Rosenblum M, Gutterman J. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 1987, 47, 2986-2989.
9. 9. Watanabe N, Yamandai N, Maeda M, et al. Recombinant human tumor necrosis factor causes regression in patients with advanced malignancies. Oncology 1994, 51, 360-365.
10. 10. Lejeune F, Lienhard D, Eggermont A, et al. Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma. Circ Shock 1994, 34, 191-197.
11. 11. Lejeune F, Lienhard D, Eggermont A, et al. Rationale for using TNF alpha and chemotheapy in regional therapy of melanoma. J Cell Biochem 1994, 56, 52-61.
12. 12. Clark S, Mcguckin MA, Hurst T, Ward BG. Effect of interferon gamma and tumor necrosis factor alpha on sensitivity to cisplatin in ovarian carcinoma cell lines. Cancer Immunol Immunother 1994, 39, 100-104.
13. 13. Aggarwal BB, Eessalu TE, Hass PE. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon. Nature 1985, 318, 665-667.
14. 14. Ruggiero V, Tavernier J, Fiers W, Baglioni C. Induction of the synthesis of tumor necrosis factor receptors by interferon-γ. J Immunol 1986, 136, 2445-245.
15. 15. Tsujimoto M, Yip YK, Vilcek J. Interferon-γ enhances expression of cellular receptors for tumor necrosis factor. J Immunol 1986, 136, 2441-2444.
16. 16. Scheurich P, Uecer U, Krönke M, Pfizenmaier K. Quantification and characterization of high-affinity membrane receptors for tumor necrosis factor on human leukemic cell lines. Int J Cancer 1986, 38, 127-133.
17. 17. Aggarwal BB, Eessalu TE. Induction of receptors for tumor necrosis factor-α by interferons is not a major mechanism for their synergistic cytotoxic response. J Biol Chem 1987, 262, 10000-10007.
18. 18. Lienhard D, Ewalenko P, Delmotte J-J, Renard N, Lejeune FJ. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 1992, 10, 52-60.
19. 19. Richter A, Sanford KK, Evans VJ. Influence of oxygen and culture media on plating efficiency of some mammalian tissue cells. J Natl Cancer Inst 1972, 49, 1705-1712.
20. 20. Küng W, Silber E, Eppenberger U. Effects of hormones and growth factors on the growth of six human breast cancer cell lines in defined medium. Contr Oncol 1986, 23, 26-32.
21. 21. Kueng W, Silber E, Eppenberger U. Quantification of cells cultured on 96-well plates. Anal Biochem 1989, 182, 16-19.
22. 22. Rothe J, Gehr G, Loetscher H, Lesslauer W. Tumor necrosis factor receptors - structure and function. Immunol Res 1992, 11, 81-90.
23. 23. Mueller H, Loop P, Liu R, et al. Differential signal transduction of epidermal-growth-factor receptors in hormone-dependent and hormone-independent human breast cancer cells. Eur J Biochem 1994, 221, 631-637.
24. 24. Jeoung D, Tang B, Sonenberg M. Effects of tumor necrosis factor-α on antimitogenicity and cell cycle-related proteins in MCF-7 cells. J Biol Chem 1995, 270, 18367-18373.
25. 25. Tamm I, Cardinale I, Sehgal PB. Interleukin-6 and 12-O-tetradecanoyl phorbol-23-acetate act synergistically in inducing cell-cell separation and migration of human breast cancer. Cytokine 1991, 3, 212-223.
26. 26. Lin J-X, Vilcek J. Tumor necrosis factor and interleukin-1 cause a rapid and transient stimulation of c-fos and c-myc mRNA levels in human fibroblasts. J Biol Chem 1987, 262, 11908-11911.
27. 27. Wosikowski K, Eppenberger U, Küng W, Nagamine Y, Mueller H. c-fos, c-jun and c-myc expressions are not growth rate limiting for the human MCF-7 breast cancer cells. Biochem Biophys Res Commun 1992, 188, 1067-1076.
28. 28. Hanazawa S, Takeshita A, Amano S, et al. Tumor necrosis factor-α induces expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells. J Biol Chem 1993, 268, 9526-9532.
29. 29. Wiegmann K, Schütze S, Kampen E, Machleidt T, Krönke W. Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J Biol Chem 1992, 267, 17997-18001.
30. 30. Tartaglia LA, Rothe M, Hu Y-F, Gocddel DV. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptors. Cell 1993, 73, 213-216.